Get started
Author

David Truong

Observed names: D Truong, Daivd Truong
ORCID: 0000-0002-3190-784X
Observed ORCID: 0000-0002-3190-784X
OpenAlex ID: A5101697216
Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting
2018 · Arshia Alimohammadi, Julie Holeksa, et al. · Open Forum Infectious Diseases · 51
PDF
COVID-19 in Homeless Populations: Unique Challenges and Opportunities
2020 · Brian Conway, David Truong, et al. · Future Virology · 44
PDF
Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject drugs in Vancouver’s Downtown Eastside
2018 · Arshia Alimohammadi, Julie Holeksa, et al. · Canadian Liver Journal · 25
PDF
Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian Study
2022 · Arif Sarowar, Carla S. Coffin, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 14
Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C virus infection in Vancouver, Canada
2019 · Julie Holeksa, Tianna Magel, et al. · International Journal of Drug Policy · 12
THU-114-A comparison of currently available direct acting antiviral HCV therapy in Canada: On the path to elimination
2019 · Arshia Alimohammadi, Tianna Magel, et al. · Journal of Hepatology · 5
Evidence of Diversion of Hydromorphone Prescribed as Safe Supply: A Pilot Study
2025 · Brian Conway, Shana Yi, et al. · The Canadian Journal of Addiction · 3
Community Pop‐Up Clinic: Cascade of Care and HCV Treatment of Vancouver's Inner‐City PWID Populations
2024 · Shana Yi, Christina Wiesmann, et al. · Journal of Viral Hepatitis · 2
PDF
Harnessing the power of the community to increase vaccination among homeless populations in inner-city Vancouver
2024 · Shana Yi, Christina Wiesmann, et al. · Future Virology · 1
PDF
Barriers to Hepatitis B Treatment: A Multicentre Cross‐Sectional Registry and Survey Study by the Canadian Hepatitis B Network
2026 · Hin Hin Ko, Jordyn Vienneau, et al. · Liver International
CHIME : Sofosbuvir/Velpatasvir (S/V) for the Treatment of HCV Infection Among Vulnerable Inner‐City Residents
2025 · Brian Conway, Shana Yi, et al. · Journal of Viral Hepatitis
SAT-033 Using community partnerships to achieve micro-elimination of HCV and HIV in inner-city Vancouver
2025 · Shana Yi, Christina Wiesmann, et al. · Journal of Hepatology
A Comparison of Sofosbuvir/velpatasvir (s/v) and Glecaprevir/pibrentasvir (g/p) for the Treatment of Hcv Infection Among Hcv-infected People Who Use Drugs (pwud)
2024 · Shana Yi, David Truong, et al. · Journal of Virus Eradication
Sofosbuvir/Velpatasvir (S/V) for the treatment of HCV infection among vulnerable inner-city residents: extending the results of clinical trial part 2
2023 · Brian Conway, Rossitta Yung, et al. · Journal of Hepatology
The Community Pop-Up Clinic (CPC): a unique strategy to achieve HCV elimination in the inner city
2022 · Brian Conway, Shawn Sharma, et al. · Journal of Hepatology
Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users: the grand plan study
2020 · Brian Conway, David Truong, et al. · Journal of Hepatology
PDF
Overdose events among active drug users successfully treated for HCV: the impact of homelessness
2020 · Tianna Magel, Kelli Wuerth, et al. · Journal of Hepatology
381 Treatment of Hcv Infection Among People Who Use Drugs (pwud): a Longitudinal Real-life Cohort
2020 · Tianna Magel, Kelli Wuerth, et al. · Gastroenterology
THU-126-HCV treatment outcomes among current and remote injection drug users: Real-life data
2019 · Brian Conway, Tianna Magel, et al. · Journal of Hepatology
A173 Evaluation of Liver Fibrosis Scores Post-hcv Svr in People Who Inject Drugs
2018 · T Raycraft, A Singh, et al. · Journal of the Canadian Association of Gastroenterology
Works count: 20
Citation count: 157
H-index: 5
I10-index: 5
Year
Topic
Type